)
HCW Biologics (HCWB) investor relations material
HCW Biologics Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Offering details and pricing
Registration statement covers resale of 427,046 shares of common stock issued on May 22, 2026, plus up to 2,419,929 shares issuable upon exercise of pre-funded warrants and up to 2,846,975 shares issuable upon exercise of common stock purchase warrants, all related to a May 21, 2026 Securities Purchase Agreement.
Shares and warrants are being registered for resale by selling stockholders, not as a primary offering.
Shares and warrant shares are fully paid, nonassessable, and validly issued upon exercise and payment of applicable exercise prices.
Management team and governance
Registration statement signed by CEO Hing C. Wong, CFO Rebecca Byam, Chairman Scott T. Garrett, and directors Rick S. Greene and Lisa M. Giles.
Multiple management contracts and employment agreements are referenced, including with CEO Hing C. Wong and other executives.
Risk factors and disclosures
Certain information in exhibits has been excluded as immaterial and confidential, with the company agreeing to furnish such information to the SEC upon request.
- Shareholders approved all proposals as clinical and financial milestones were highlighted.HCWB
AGM 202615 Jun 2026 - Registering resale of 5.7M shares from PIPE; focus on immunotherapy, Nasdaq compliance risks.HCWB
Registration filing8 Jun 2026 - Financial progress, clinical trial plans, and board decisions marked the annual meeting.HCWB
AGM 20255 Jun 2026 - Q2 2024 net loss hit $15.3M as legal costs surged and liquidity risks persisted.HCWB
Q2 202429 May 2026 - Net loss widened to $26.7M on $2.2M revenue, with urgent financing needs and going concern risk.HCWB
Q3 202429 May 2026 - Lower revenue, higher net loss, and urgent need for funding amid pipeline progress.HCWB
Q4 202429 May 2026 - Net loss narrowed in Q1 2025, but liquidity and funding challenges persist.HCWB
Q1 202529 May 2026 - Net loss narrowed, legal costs fell, and debt was reduced, but revenue and funding risks persist.HCWB
Q2 202529 May 2026 - Revenue plunged and net loss narrowed, but urgent funding and compliance risks persist.HCWB
Q3 202529 May 2026
Next HCW Biologics earnings date
Next HCW Biologics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)